Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Advanced Therapeutics|January 23, 2023
Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer ExcipientJohn H Klich, Catherine M Kasse, Joseph L Mann, et al.
Matter|August 18, 2025
Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responsesJulie Baillet, John H Klich, Ben S Ou, et al.
ACS Nano|January 12, 2024
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 VaccinesBen S Ou, Julie Baillet, Vittoria C T M Picece, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Label-Free Composition Analysis of Supramolecular Polymer - Nanoparticle Hydrogels by Reversed-Phase Liquid Chromatography Coupled with a Charged Aerosol DetectorShijia Tang, Zachary Pederson, Emily L Meany, et al.
Analytical Chemistry|April 3, 2024
Label-Free Composition Analysis of Supramolecular Polymer-Nanoparticle Hydrogels by Reversed-Phase Liquid Chromatography Coupled with a Charged Aerosol DetectorShijia Tang, Zachary Pederson, Emily L Meany, et al.
International Journal of Pharmaceutics|September 14, 2017
Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imagingGeoffrey Prévot, Tina Kauss, Cyril Lorenzato, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Generation of an inflammatory niche in an injectable hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccinesEmily L Meany, John H Klich, Carolyn K Jons, et al.
Science Advances|April 11, 2025
Generation of an inflammatory niche in a hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccinesEmily L Meany, John H Klich, Carolyn K Jons, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine ResponsesBen S Ou, Julie Baillet, Maria V Filsinger Interrante, et al.
Science Advances|August 7, 2024
Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responsesBen S Ou, Julie Baillet, Maria V Filsinger Interrante, et al.
Pageof 2